SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-19-010058
Filing Date
2019-09-04
Accepted
2019-09-04 16:19:11
Documents
2
Period of Report
2019-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 13872
2 ex24lutz20190828.txt EX-24 4201
  Complete submission text file 0001179110-19-010058.txt   19482
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Issuer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 NORTHBROOK DRIVE SUITE 200 TREVOSE PA 19053
Business Address
Lutz Robert Matthew (Reporting) CIK: 0001786203 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37569 | Film No.: 191074775